Literature DB >> 10508959

Microfibrillar structure of PGG-glucan in aqueous solution as triple-helix aggregates by small angle x-ray scattering.

M Gawronski1, J T Park, A S Magee, H Conrad.   

Abstract

The conformation of polysaccharide PGG-Glucan, isolated from yeast cell walls, in aqueous solution was investigated by small angle x-ray scattering (SAXS) and multidetector gel permeation chromatography coupled with postcolumn delivery (GPC/PCD) techniques in comparison with scleroglucan. It was shown that both polysaccharides exhibit a rigid rod-like conformation in aqueous solution by SAXS experiments. The mass per unit length (M/L) and radius (R) of rod cross section of PGG-Glucan were measured to be 6300 daltons/nm and 1.89 nm, while those of scleroglucan are 2300 and 0.83, respectively. Utilizing a GPC/light scattering technique, the average aggregation number of PGG-Glucan is 9, while that of scleroglucan is around 3. From the comparison of the M/L and R of the respective rod cross sections as well as their aggregation number data, it is concluded that PGG-Glucan is composed of triple helices, which tend to aggregate as triplets in solution, whereas scleroglucan is composed of a single triple helix. The aggregation number distribution of PGG-Glucan was found to range from 1 to about 25 determined by GPC/PCD. From the observation of a Debye-Scherrer ring type of peak in the macroscopic scattering cross section of PGG-Glucan by SAXS, the existence of a small amount of ordered clusters of PGG-Glucan can be deduced. The "lattice parameter" of these ordered fasces-like clusters is consistent with the radius of the individual triple-helical rods forming a microfibrillar superstructure. These results indicate that higher aggregated forms of PGG-Glucan containing up to 8 triple helices behave as ordered fasces-like clusters. We conclude that PGG-Glucan is triple-helix aggregates formed by rigid rods stacking together side by side. We propose a molecular structural model for PGG-Glucan conformations. Copyright 1999 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508959     DOI: 10.1002/(SICI)1097-0282(199911)50:6<569::AID-BIP1>3.0.CO;2-B

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  5 in total

1.  Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans.

Authors:  Chunjian Qi; Yihua Cai; Lacey Gunn; Chuanlin Ding; Bing Li; Goetz Kloecker; Keqing Qian; John Vasilakos; Shinobu Saijo; Yoichiro Iwakura; John R Yannelli; Jun Yan
Journal:  Blood       Date:  2011-04-29       Impact factor: 22.113

2.  Improved antimicrobial host defense in mice following poly-(1,6)-β-D-glucopyranosyl-(1,3)-β-D-glucopyranose glucan treatment by a gender-dependent immune mechanism.

Authors:  Courtni T Newsome; Estefany Flores; Alfred Ayala; Stephen Gregory; Jonathan S Reichner
Journal:  Clin Vaccine Immunol       Date:  2011-10-05

Review 3.  Combined yeast-derived beta-glucan with anti-tumor monoclonal antibody for cancer immunotherapy.

Authors:  Jingjing Liu; Lacey Gunn; Richard Hansen; Jun Yan
Journal:  Exp Mol Pathol       Date:  2009-01-21       Impact factor: 3.362

4.  Immunoregulatory Activity of the Natural Product Laminarin Varies Widely as a Result of Its Physical Properties.

Authors:  Alyson J Smith; Bridget Graves; Robert Child; Peter J Rice; Zuchao Ma; Douglas W Lowman; Harry E Ensley; Kendal T Ryter; Jay T Evans; David L Williams
Journal:  J Immunol       Date:  2017-12-15       Impact factor: 5.422

Review 5.  Spent Brewer's Yeast as a Source of Insoluble β-Glucans.

Authors:  Ionut Avramia; Sonia Amariei
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.